NCT04798781: Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma |
|
|
| Active, not recruiting | 2 | 16 | US | Telatinib, Keytruda, pembrolizumab | Andrew Hendifar, MD, EOC Pharma | Gastric Cancer, Hepatocellular Carcinoma | 02/24 | 02/25 | | |
NCT06445114: Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer |
|
|
| Not yet recruiting | 2 | 50 | US | Cisplatin, Chemoradiation | Zachary Zumsteg | Oropharyngeal Cancer, Carcinoma | 03/32 | 03/32 | | |
